GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Study Explores How Lifestyle Behaviors Differently Impact Cancer Risks in Men and Women

by GOAI
Share To

A recent study has examined the connection between behavioral factors and cancer outcomes, focusing on differences related to sex and gender. Researchers conducted an umbrella review to analyze how lifestyle elements influence cancer risks, compiling data from multiple systematic reviews. The findings highlight the complex interplay between behavior and cancer development, offering insights into how these factors vary across sexes.

The study, led by Marozoff et al., synthesized existing research to provide a comprehensive overview of the relationship between lifestyle behaviors—such as diet, physical activity, smoking, and alcohol consumption—and cancer risks. By reviewing numerous systematic studies, researchers aimed to identify patterns that could explain variations in cancer outcomes based on sex and gender. The analysis revealed significant differences in how certain behaviors impact cancer risk for men versus women. This work adds to ongoing efforts to understand the role of behavioral factors in disease prevention and management while emphasizing the importance of considering sex-specific influences in health research.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 29, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
LATEST
Taiwan Healthcare Expo Opens With €200 Million Czech Deal as Global Buyers Flock to Taipei
2025-12-07
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
Scroll to Top